Loading...
Applied DNA Sciences, Inc.
APDN•NASDAQ
Healthcare
Medical - Diagnostics & Research
$4.98
$-0.27(-5.14%)
Applied DNA Sciences, Inc. (APDN) Financial Performance & Income Statement Overview
Review Applied DNA Sciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-74.33%
↓ 74.33%
Operating Income Growth
-28.04%
↓ 28.04%
Net Income Growth
29.70%
↑ 29.70%
Operating Cash Flow Growth
-120.52%
↓ 120.52%
Operating Margin
-344.11%
↓ 344.11%
Gross Margin
40.76%
↑ 40.76%
Net Profit Margin
-825.19%
↓ 825.19%
ROE
-281.09%
↓ 281.09%
ROIC
-117.07%
↓ 117.07%
Applied DNA Sciences, Inc. (APDN) Income Statement & Financial Overview
Review Applied DNA Sciences, Inc.'s (APDN) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.20M | $813107.00 | $797519.00 | $929631.00 |
| Cost of Revenue | $512510.00 | $568208.00 | $552287.00 | $820306.00 |
| Gross Profit | $684107.00 | $244899.00 | $245232.00 | $109325.00 |
| Gross Profit Ratio | $0.57 | $0.30 | $0.31 | $0.12 |
| R&D Expenses | $1.02M | $831710.00 | $913031.00 | $726868.00 |
| SG&A Expenses | $2.63M | $2.68M | $2.68M | $3.000M |
| Operating Expenses | $3.65M | $3.52M | $3.59M | $3.73M |
| Total Costs & Expenses | $4.16M | $4.08M | $4.14M | $4.55M |
| Interest Income | $71440.00 | $91329.00 | $36295.00 | $15352.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $76985.00 | $134163.00 | $186326.00 |
| EBITDA | -$2.96M | -$3.19M | -$3.21M | -$3.43M |
| EBITDA Ratio | -$2.48 | -$3.93 | -$4.03 | -$3.69 |
| Operating Income | -$2.96M | -$3.27M | -$3.35M | -$3.62M |
| Operating Income Ratio | -$2.48 | -$4.02 | -$4.20 | -$3.89 |
| Other Income/Expenses (Net) | $295288.00 | -$42488.00 | $5.20M | -$876032.00 |
| Income Before Tax | -$2.67M | -$3.31M | $1.85M | -$4.49M |
| Income Before Tax Ratio | -$2.23 | -$4.08 | $2.32 | -$4.83 |
| Income Tax Expense | $14.79M | $0.00 | $0.00 | $132021.00 |
| Net Income | -$2.64M | -$3.30M | $1.88M | -$4.47M |
| Net Income Ratio | -$2.21 | -$4.05 | $2.36 | -$4.81 |
| EPS | -$0.08 | -$0.19 | $0.47 | -$5.13 |
| Diluted EPS | -$0.08 | -$0.19 | $0.47 | -$5.13 |
| Weighted Avg Shares Outstanding | $31.52M | $17.74M | $4.01M | $871319.00 |
| Weighted Avg Shares Outstanding (Diluted) | $31.52M | $17.74M | $4.01M | $871319.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan